Skip to main content

Table 2 Factors related to HIV sero-discordant/concordant status

From: HIV sero-discordance among married HIV patients initiating anti-retroviral therapy in northern Vietnam

Characteristics

Variable

Concordance N = 121

Discordance N = 167

Adjusted odds ratio

N (%)

95% CI

N (%)

95% CI

(95% CI)

p value

Sex

Male

62 (29%)

23–35

154 (71%)

65–77

1

 

Female

59 (82%)

71–90

13 (18%)

10–29

4.8 (2.0–11.4)

<0.001

Education

Secondary or less

56 (40%)

32–49

84 (60%)

51–68

1

 

High school

45 (39%)

30–48

71 (61%)

52–70

1.2 (0.6–2.3)

NS

College/university

20 (63%)

44–78

12 (37%)

22–56

3.2 (1.2–8.7)

0.025

Occupation

Unemployed

14 (27%)

16–41

38 (73%)

59–84

0.8 (0.3–1.9)

NS

Employed

107 (45%)

39–52

129 (55%)

48–61

1

 

Having children

Yes

89 (40%)

34–47

132 (60%)

53–66

1

 

No

32 (48%)

36–60

35 (52%)

40–64

1.3 (0.6–2.7)

NS

Resident’s area

Dong Trieu

25 (68%)

50–81

12 (32%)

19–49

5.2 (1.7–15.4)

0.003

Uong Bi

20 (47%)

31–62

23 (53%)

38–69

2.5 (0.997–6.5)

0.051

Yen Hung

16 (46%)

29–63

19 (54%)

37–71

2.4 (0.9–6.8)

NS

Ha Long

60 (35%)

28–42

113 (65%)

58–72

1

 

Mode of HIV infection

Sexual intercourse

85 (60%)

51–68

57 (40%)

32–48

1

 

IDU

26 (21%)

14–29

100 (79%)

71–86

0.4 (0.2–1.1)

NS

Do not know

10 (42%)

23–63

14 (58%)

37–77

0.6 (0.2–2.0)

NS

Hepatitis coinfection

Yes

29 (32%)

23–42

62 (68%)

54–77

0.6 (0.3–1.3)

NS

No

92 (47%)

40–54

105 (53%)

46–60

1

 

History of IDU

Yes

31 (22%)

16–30

109 (78%)

70–84

0.6 (0.3–1.3)

NS

No

90 (61%)

52–69

58 (39%)

31–48

1

 

Clinical stage

Stage 3 or 4

68 (49%)

40–57

71 (51%)

43–59

1

 

Stage 1 or 2

53 (36%)

28–44

96 (64%)

56–72

0.9 (0.4–1.7)

NS

Duration of known HIV infection

≥2 years

80 (46%)

39–54

93 (54%)

46–61

1

NS

<2 year

41 (36%)

27–45

74 (64%)

55–73

0.6 (0.3–1.3)

NS

History of TB

Yes

10 (25%)

13–41

30 (75%)

58–87

1

 

No

111 (45%)

39–51

137 (55%)

49–61

0.2 (0.05–0.8)

0.026

CD4 cell count

≥100/µl

73 (52%)

43–60

68 (48%)

40–57

1

 

<100/µl

48 (33%)

25–41

99 (67%)

59–75

1.1 (0.6–2.2)

NS

Viral load

≥100,000 copies/ml

40 (39%)

29–49

63 (61%)

51–70

1.1 (0.5–2.1)

NS

<100,000 copies/ml

81 (44%)

37–51

104 (56%)

49–63

1

Â